Compatibility «Captopril» and «Amlodipine+Valsartan»
Between «Captopril» and «Amlodipine+Valsartan» found 5 dangerous and 11 negative interactions, joint admission is not recommended without consulting a doctor.
Interaction tableCompare |
Amlodipine+Valsartan |
✘Captopril Analogs | |
✘Amlodipine+Valsartan [Amlodipine and more 1Valsartan] Analogs |
-
Interactions Captopril with Amlodipine+Valsartan
-
Dangerous interactions
Double blockade of RAAS ARA II, ACE inhibitors or aliskiren is associated with an increased risk of hypotension, hyperkalemia and changes in renal function (including acute renal failure) compared to monotherapy. Concomitant use of ARA II with ACE inhibitors is contraindicated in patients with diabetic nephropathy and is not recommended in other patients. Double blockade of the RAAS with the combined use of ARA II, ACE inhibitors or aliskiren is associated with an increased risk of hypotension, hyperkalemia and changes in renal function (including acute renal failure) compared to monotherapy. Double blockade of the RAAS with the use of ARA II, ACE inhibitors or aliskiren (renin inhibitor) is associated with an increased risk of hypotension, syncope, hyperkalemia and impaired renal function (including acute renal failure). ACE inhibitors (C09A) + angiotensin ii receptor antagonists => Are associated with an increased risk of arterial hypotension, syncope, hyperkalemia and impaired renal function (in pm acute renal failure) compared with monotherapy. -
Negative interactions
Other antihypertensive and antianginal drugs. Amlodipine can be safely used to treat hypertension together with thiazide diuretics, beta-blockers or ACE inhibitors. Concomitant use of ARA II, including valsartan, with other agents that affect RAAS (such as ACE inhibitors and aliskiren) is associated with an increased incidence of arterial hypotension, hyperkalemia and changes in renal function compared with monotherapy. With the simultaneous use of lithium preparations with ACE inhibitors and ARA II, a reversible increase in the lithium content in blood serum and an increase in toxic manifestations in this regard were noted, therefore, it is recommended to monitor the lithium content in blood serum. Captopril can be safely used in combination with other antihypertensive drugs (such as beta‑blockers or long-acting 'slow' calcium channel blockers). The effect of captopril is enhanced by the use of antihypertensive drugs that cause the release of renin. Concomitant use of ACE inhibitors with angiotensin II receptor antagonists. (ARA II) is contraindicated in patients with diabetic nephropathy and is not recommended in other patients. Simultaneous use of captopril with potassium-sparing diuretics (such as spironolactone, eplerenone, triamterene, amiloride), potassium preparations, potassium-containing salt substitutes and other drugs capable of increasing the potassium content in blood serum (including angiotensin II receptor antagonists, heparin, tacrolimus, cyclosporine; drugs containing cotrimoxazole [trimethoprim + sulfamethoxazole]) may lead to a significant increase in the potassium content in blood plasma. Other antihypertensive drugs. NSAIDs, including selective cyclooxygenase‑2 (COX‑2) inhibitors and acetylsalicylic acid in doses of 3 g/day and above, can reduce the antihypertensive effect of diuretics and other antihypertensive agents. -
Positive interactions
It is possible to enhance the antianginal and antihypertensive effects of BMCC when combined with thiazide and loop diuretics, ACE inhibitors, beta-blockers and nitrates. -
Unclear interactions
In patients who had suffered a myocardial infarction, a doubling of serum creatinine was observed in 4.2% of patients treated with valsartan and in 3.4% of patients treated with captopril.
-
Dangerous interactions
Decoding the colors of interactions and contraindications
Dangerous | — | a pronounced negative interaction or contraindication. |
Negative | — | negative interaction or side effect that may reduce effectiveness. |
Positive | — | the interaction can SOMETIMES be used as a positive (often a dose adjustment is needed), or it is an indication of the drug. |
No | — | the drugs do NOT interact, which is separately indicated in the instructions. |
Unclear | — | the system failed to pre-assess the danger. |
Video instruction
Additional information
- Kiberis checks interactions and evaluates drug compatibility online right in the instructions thanks to the latest artificial intelligence technologies. The accuracy of finding is more than 95%, the accuracy of the hazard assessment is more than 80%. The online medical service takes into account all the drug groups of the selected drugs and all their components. And since the database contains 25,000 drugs with detailed instructions, not every pharmacologist can compete with our artificial intelligence. List of popular interactions.
- Why do I need to
- Avoid dangerous prescriptions for your patients.
- Check the contraindications.
- Evaluate the safety of therapy in the treatment of children.
- See the compatibility of drugs with alcohol (enter it as a drug).
- Point the doctor to the found interaction - you may need to adjust the therapy.
- The use of information about interactions is only possible as an introduction. This information should not be used to adjust therapy without consulting a specialist.
- The article is written: artificial intelligence Kiberis
- Sources: official instructions for medicines and their active substances, as well as inter-group interactions described in medical studies and textbooks.
- Total analyzed: 169,974,420 possible combinations of drugs and their components were found 412,510 interacting combinations.
- Medicine section: Standard evidence-based medicine
- The date of the last update of the interaction database: 2024-05-02
Category - medicine